Viviana Falcón

Viviana Falcón

Auto-generated profile, based on publicly available information

Viviana Falcón

Center for Genetic Engineering and Biotechnology (CIGB)

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1997 in Vaccine
Verified
Journal Article
Closed access
MCMario Canales
Mario Canales
AEAntonio Enríquez
Antonio Enríquez
EREduardo Ramos
Eduardo Ramos
DCDeborah Cabrera
Deborah Cabrera
HDHubert Dandie
Hubert Dandie
Jose De La FuenteJose De La Fuente
Jose De La Fuente

1 March 1994 in Journal of Biotechnology
Verified
Journal Article
Closed access
Manuel Rodriguez-ValleManuel Rodriguez-Valle
Manuel Rodriguez-Valle
RRRoger Rubiera
Roger Rubiera
MPManuel Penichet
Manuel Penichet
RMRaquel Montesinos
Raquel Montesinos
JCJosé Cremata
José Cremata
Jose De La FuenteJose De La Fuente
Jose De La Fuente

1 October 2004 in Cancer Research
Verified
Journal Article
Open access
PDF file
SPSilvio E. Perea
Silvio E. Perea
OROsvaldo Reyes
Osvaldo Reyes
YIYaquelin Puchades Izaguirre
Yaquelin Puchades Izaguirre
OMOsmani Mendoza
Osmani Mendoza
Nelson Santiago VispoNelson Santiago Vispo
Nelson Santiago Vispo
DADaniel F. Alonso
Daniel F. Alonso
Protein Kinase (casein kinase 2, CK2) is a serine-threonine kinase that is frequently dysregulated in many human tumors. Therefore we hypothesized that peptides capable of binding to the CK2 acidic domain may exhibit potential anticancer properties. By screening a random cyclic peptide phage display library, we have identified a novel peptide, P15, that abrogated CK2 phosphorylation by blocking the substrate in vitro. To verify its potential antineoplastic effect, P15 was fused to the cell-penetrating peptide derived from the HIV-Tat protein. Interestingly, P15-Tat induced apoptosis as evidenced by rapid caspase activation and cellular cytotoxicity in a variety of tumor cell lines. Furthermore, direct injection of P15-Tat into C57BL6 mice bearing day 7-established solid tumors, resulted in substantial regression of the tumor mass. Our findings describe a new proapoptotic cyclic peptide that blocks the CK2 phosphorylation and exhibits antitumor effect in vivo, indicating that the P15 peptide may potentially be used clinically to treat solid tumors or as an adjuvant for cancer therapy.

25 June 2008 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SPSilvio E. Perea
Silvio E. Perea
OROsvaldo Reyes
Osvaldo Reyes
IBIdania Baladron
Idania Baladron
YPYasser Perera
Yasser Perera
HFHernán Farina
Hernán Farina
BABoris Acevedo
Boris Acevedo

9 September 2005 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
JLJosé Luna-Muñoz
José Luna-Muñoz
FGFrancisco García-Sierra
Francisco García-Sierra
VFViviana Falcón
Viviana Falcón
IMIvón Menéndez
Ivón Menéndez
LCLaura Chávez-Macías
Laura Chávez-Macías
RMRaúl Mena
Raúl Mena
Neurofibrillary tangles (NFTs) are the neuropathological hallmarks in Alzheimer's disease (AD). Densities of NFTs correlate with the dementia status. NFTs reflect the intracellular accumulation of abnormal paired helical filaments (PHFs) composed of

5 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ECEduardo Canales
Eduardo Canales
YCYamilet Coll
Yamilet Coll
IHIngrid Hernández
Ingrid Hernández
RPRoxana Portieles
Roxana Portieles
MGMayra Rodríguez García
Mayra Rodríguez García
OBOrlando OBH Borras-Hidalgo
Orlando OBH Borras-Hidalgo
Huanglongbing (HLB) constitutes the most destructive disease of citrus worldwide, yet no established efficient management measures exist for it. Brassinosteroids, a family of plant steroidal compounds, are essential for plant growth, development and stress tolerance. As a possible control strategy for HLB, epibrassinolide was applied to as a foliar spray to citrus plants infected with the causal agent of HLB, ‘Candidatus Liberibacter asiaticus’. The bacterial titers were reduced after treatment with epibrassinolide under both greenhouse and field conditions but were stronger in the greenhouse. Known defense genes were induced in leaves by epibrassinolide. With the SuperSAGE technology combined with next generation sequencing, induction of genes known to be associated with defense response to bacteria and hormone transduction pathways were identified. The results demonstrate that epibrassinolide may provide a useful tool for the management of HLB.